Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma Journal:Therapeutic Advances in Medical Oncology | 2019 | 3 |